Table 4.

SPM results for the location of the brain regions showing a significant positive correlation between the changes in CAARS A (inattention) with medication treatment (compared with measures obtained before treatment initiation) and the DA increases induced by intravenous MP obtained during the long-term treatment condition

Region	BA/nucleus	Cluster size	x	y	z	T value	p_cluster-corr
R medial frontal	BA 9	1063	18	38	36	5.85	0.000
R medial frontal	BA 8		0	26	44
L cingulated	BA 24		−14	0	38
L thalamus		527	−38	−30	2	5.47	0.003
L superior temporal	BA 22		−46	−24	6
L superior temporal	BA 22		−60	−34	12
L caudate	BA 47	955	−10	10	−1	5.40	0.000
L putamen			−38	8	−20
L inferior frontal			−40	16	−24
R putamen		629	40	−4	−2	5.05	0.001
R putamen			32	10	2
R VS			26	0	−6

L, Left; R, right.